Modified structure of the human serotonin transporter promoter

Molecular Psychiatry

Volumn 5, Issue 1, 2000, Pages 110-115

  Flattem, N L ^a   Blakely, R D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Gene; Promoter; Serotonin; Structure; Transporter

Indexed keywords

SEROTONIN TRANSPORTER;

ARTICLE; BINDING SITE; GENE INSERTION; HUMAN; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; TRANSCRIPTION INITIATION;

EID: 0033952855     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000585     Document Type: Article

References (25)

1. 1 Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
2. 2 Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 1998; 81: 58-63.
3. 3 Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997; 2: 247-250.
4. 4 Bradley CC, Blakely RD. Alternative splicing of the human serotonin transporter gene. J Neurochem 1997; 69: 1356-1367.
5. 5 Rudnick G, Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1993; 1144: 249-263.
6. 6 Povlock SL, Amara SG. The structure and function of norepinephrine, dopamine, and serotonin transporters. In: Reith MEA (ed). Neurotransmitter Transporters: Structure, Function, and Regulation. Humana Press: Totowa, NJ, 1997, pp 1-28.
7. 7 Fuller RW, Wong DT. Serotonin uptake and serotonin uptake inhibition. Ann NY Acad Sci 1990; 600: 68-78.
8. 8 Barker EL, Blakely RD. Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, 1995, pp 321-333.
9. 9 Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS et al. Antidepressant-and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993; 90: 2542-2546.
10. 10 Rudnick G, Wall SC. The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 1992; 89: 1817-1821.
11. 11 Gatley SJ, Pan DF, Chen RY, Chaturvedi G, Ding YS. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 1996; 58: PL231-PL239.
12. 12 Di Bella D, Catalano M, Balling U, Smeraldi E, Lesch KP. Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE. Am J Med Genet 1996; 67: 541-545.
13. 13 Altemus M, Murphy DL, Greenberg B, Lesch KP. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. Am J Med Genet 1996; 67; 409-411.
14. 14 Tuomisto J, Tukiainen E, Ahlfors UG. Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology 1979; 65: 141-147.
15. 15 Paul SM, Rehavi M, Skolnick P, Ballenger JC, Goodwin FK. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin 'transporter'. Arch Gen Psychiatry 1981; 38: 1315-1317.
16. 16 Stanley M, Virgilio J, Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982; 216: 1337-1339.
17. 17 Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621-2624.
18. 18 Delbruck SJ, Wendel B, Grunewald I, Sander T, Morris-Rosendahl D, Crocq MA et al. A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. Cytogenet Cell Genet 1997; 79: 214-220.
19. 19 Flattem NL, Bradley C, Meltzer HY, Austin MC, Lewis DA, Blakely RD. Polymorphic promoter and alternative splicing in the human serotonin transporter: are they predictive of mental illness. Soc Neurosci Abs 1997; 23: 338.9.
20. 20 Michaelovsky E, Frisch A, Rockah R, Peleg L, Magal N, Shohat M et al. A novel allele in the promoter region of the human serotonin transporter gene. Mol Psychiatry 1999; 4: 97-99.
21. 21 Lesch KP, Balling U, Gross J, Strass K, Wolozin BL, Murphy DL et al. Organization of the human serotonin transporter gene. J Neural Transm 1994; 95: 157-162.
22. 22 Cancel G, Gourfinkel-An I, Stevanin G, Didierjean O, Abbas N, Hirsch E et al. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease. Hum Mut 1998; 11: 23-27.
23. 23 Mortensen OV, Thomassen M, Larsen MB, Whittemore SR, Wilborg O. Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells. Brain Res Mol Brain Res 1999; 68: 141-148.
24. 24 Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucl Acids Res 1995; 23: 4878-4884.
25. 25 Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.